Ultra-early intravenous stroke thrombolysis: do all patients benefit similarly?
- PMID: 23970791
- DOI: 10.1161/STROKEAHA.111.000819
Ultra-early intravenous stroke thrombolysis: do all patients benefit similarly?
Abstract
Background and purpose: We previously reported increased benefit and reduced mortality after ultra-early stroke thrombolysis in a single center. We now explored in a large multicenter cohort whether extra benefit of treatment within 90 minutes from symptom onset is uniform across predefined stroke severity subgroups, as compared with later thrombolysis.
Methods: Prospectively collected data of consecutive ischemic stroke patients who received i.v. thrombolysis in 10 European stroke centers were merged. Logistic regression tested association between treatment delays, as well as excellent 3-month outcome (modified Rankin scale, 0-1), and mortality. The association was tested separately in tertiles of baseline National Institutes of Health Stroke Scale.
Results: In the whole cohort (n=6856), shorter onset-to-treatment time as a continuous variable was significantly associated with excellent outcome (P<0.001). Every fifth patient had onset-to-treatment time≤90 minutes, and these patients had lower frequency of intracranial hemorrhage. After adjusting for age, sex, admission glucose level, and year of treatment, onset-to-treatment time≤90 minutes was associated with excellent outcome in patients with National Institutes of Health Stroke Scale 7 to 12 (odds ratio, 1.37; 95% confidence interval, 1.11-1.70; P=0.004), but not in patients with baseline National Institutes of Health Stroke Scale>12 (odds ratio, 1.00; 95% confidence interval, 0.76-1.32; P=0.99) and baseline National Institutes of Health Stroke Scale 0 to 6 (odds ratio, 1.04; 95% confidence interval, 0.78-1.39; P=0.80). In the latter, however, an independent association (odds ratio, 1.51; 95% confidence interval, 1.14-2.01; P<0.01) was found when considering modified Rankin scale 0 as outcome (to overcome the possible ceiling effect from spontaneous better prognosis of patients with mild symptoms). Ultra-early treatment was not associated with mortality.
Conclusions: I.v. thrombolysis within 90 minutes is, compared with later thrombolysis, strongly and independently associated with excellent outcome in patients with moderate and mild stroke severity.
Keywords: emergencies; ischemic stroke; onset to needle time; outcome; thrombolysis.
Similar articles
-
Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke.Int J Stroke. 2014 Dec;9(8):985-91. doi: 10.1111/j.1747-4949.2012.00879.x. Epub 2012 Sep 13. Int J Stroke. 2014. PMID: 22973986
-
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717
-
Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.J Clin Neurosci. 2014 Aug;21(8):1428-32. doi: 10.1016/j.jocn.2014.03.014. Epub 2014 Jun 26. J Clin Neurosci. 2014. PMID: 24980628
-
Is bridging with intravenous thrombolysis of any benefit in endovascular therapy for acute ischemic stroke?World Neurosurg. 2014 Sep-Oct;82(3-4):e453-8. doi: 10.1016/j.wneu.2013.01.097. Epub 2013 Feb 1. World Neurosurg. 2014. PMID: 23376392 Review.
-
Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1. Cerebrovasc Dis. 2012. PMID: 22868870 Review.
Cited by
-
Service delivery in acute ischemic stroke patients: Does sex matter?Eur J Neurol. 2024 Jul;31(7):e16287. doi: 10.1111/ene.16287. Epub 2024 Mar 30. Eur J Neurol. 2024. PMID: 38553933 Free PMC article.
-
A new machine learning algorithm with high interpretability for improving the safety and efficiency of thrombolysis for stroke patients: A hospital-based pilot study.Digit Health. 2023 Jan 3;9:20552076221149528. doi: 10.1177/20552076221149528. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 36636727 Free PMC article.
-
EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) registry: basis and methodology of a pan-European prospective ischaemic stroke revascularisation treatment registry.BMJ Open. 2021 Aug 9;11(8):e042211. doi: 10.1136/bmjopen-2020-042211. BMJ Open. 2021. PMID: 34373287 Free PMC article.
-
Intravenous Thrombolysis Benefits Mild Stroke Patients With Large-Artery Atherosclerosis but No Tandem Steno-Occlusion.Front Neurol. 2020 May 5;11:340. doi: 10.3389/fneur.2020.00340. eCollection 2020. Front Neurol. 2020. PMID: 32431662 Free PMC article.
-
Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration.BMJ Open. 2018 Sep 17;8(9):e023265. doi: 10.1136/bmjopen-2018-023265. BMJ Open. 2018. PMID: 30224398 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
